Your browser doesn't support javascript.
loading
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Ozga, Michael; Nicolet, Deedra; Mrózek, Krzysztof; Yilmaz, Ayse S; Kohlschmidt, Jessica; Larkin, Karilyn T; Blachly, James S; Oakes, Christopher C; Buss, Jill; Walker, Christopher J; Orwick, Shelley; Jurinovic, Vindi; Rothenberg-Thurley, Maja; Dufour, Annika; Schneider, Stephanie; Sauerland, Maria Cristina; Görlich, Dennis; Krug, Utz; Berdel, Wolfgang E; Woermann, Bernhard J; Hiddemann, Wolfgang; Braess, Jan; Subklewe, Marion; Spiekermann, Karsten; Carroll, Andrew J; Blum, William G; Powell, Bayard L; Kolitz, Jonathan E; Moore, Joseph O; Mayer, Robert J; Larson, Richard A; Uy, Geoffrey L; Stock, Wendy; Metzeler, Klaus H; Grimes, H Leighton; Byrd, John C; Salomonis, Nathan; Herold, Tobias; Mims, Alice S; Eisfeld, Ann-Kathrin.
Affiliation
  • Ozga M; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Nicolet D; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Mrózek K; Alliance Statistics and Data Management Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Yilmaz AS; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. krzysztof.mrozek@osumc.edu.
  • Kohlschmidt J; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA. krzysztof.mrozek@osumc.edu.
  • Larkin KT; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Blachly JS; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Oakes CC; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Buss J; Alliance Statistics and Data Management Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Walker CJ; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Orwick S; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Jurinovic V; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Rothenberg-Thurley M; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Dufour A; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Schneider S; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Sauerland MC; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Görlich D; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Krug U; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Berdel WE; The Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
  • Woermann BJ; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Braess J; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Subklewe M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Carroll AJ; Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.
  • Blum WG; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Powell BL; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Kolitz JE; Department of Medicine 3, Klinikum Leverkusen, Leverkusen, Germany.
  • Moore JO; Department of Medicine, Hematology and Oncology, University of Münster, Münster, Germany.
  • Mayer RJ; German Society of Hematology and Oncology, Berlin, Germany.
  • Larson RA; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Uy GL; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stock W; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.
  • Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Grimes HL; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Byrd JC; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Salomonis N; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Herold T; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mims AS; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Eisfeld AK; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Leukemia ; 38(1): 45-57, 2024 01.
Article in En | MEDLINE | ID: mdl-38017103

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Sex Characteristics Limits: Adult / Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Sex Characteristics Limits: Adult / Female / Humans / Male Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Type: Article Affiliation country: United States